Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Langenberg

Showing results (141-150 of 399) with videos related to

Pageof 40
Sort By:
Ebiomedicine|June 15, 2024
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Journal of the National Cancer Institute|July 3, 2015
Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization AnalysisKevin T Nead, Stephen J Sharp, Deborah J Thompson, et al.
Nature Genetics|January 31, 2012
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetesAmélie Bonnefond, Nathalie Clément, Katherine Fawcett, et al.
Nature Medicine|February 12, 2020
Using human genetics to understand the disease impacts of testosterone in men and womenKatherine S Ruth, Felix R Day, Jessica Tyrrell, et al.
Metabolites|July 20, 2019
Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS)Mary C Playdon, Amit D Joshi, Fred K Tabung, et al.
Diabetes|February 2, 2011
Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistanceN Maneka G De Silva, Rachel M Freathy, Tom M Palmer, et al.
Nature Communications|March 7, 2019
Assessing the causal association of glycine with risk of cardio-metabolic diseasesLaura B L Wittemans, Luca A Lotta, Clare Oliver-Williams, et al.
Nature Medicine|March 22, 2022
Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthmaPriyadarshini Kachroo, Isobel D Stewart, Rachel S Kelly, et al.
Nature Medicine|July 19, 2024
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklistSiew S Lim, Zhila Semnani-Azad, Mario L Morieri, et al.
Pageof 40

Showing results (141-150 of 399) with videos related to

Sort By:
Pageof 40
Ebiomedicine|June 15, 2024
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Journal of the National Cancer Institute|July 3, 2015
Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization AnalysisKevin T Nead, Stephen J Sharp, Deborah J Thompson, et al.
Nature Genetics|January 31, 2012
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetesAmélie Bonnefond, Nathalie Clément, Katherine Fawcett, et al.
Nature Medicine|February 12, 2020
Using human genetics to understand the disease impacts of testosterone in men and womenKatherine S Ruth, Felix R Day, Jessica Tyrrell, et al.
Metabolites|July 20, 2019
Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS)Mary C Playdon, Amit D Joshi, Fred K Tabung, et al.
Diabetes|February 2, 2011
Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistanceN Maneka G De Silva, Rachel M Freathy, Tom M Palmer, et al.
Nature Communications|March 7, 2019
Assessing the causal association of glycine with risk of cardio-metabolic diseasesLaura B L Wittemans, Luca A Lotta, Clare Oliver-Williams, et al.
Nature Medicine|March 22, 2022
Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthmaPriyadarshini Kachroo, Isobel D Stewart, Rachel S Kelly, et al.
Nature Medicine|July 19, 2024
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklistSiew S Lim, Zhila Semnani-Azad, Mario L Morieri, et al.
Pageof 40